Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05260957
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT03035331
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +31 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT03061188
- Conditions
- Advanced Solid Neoplasm, Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT01527045
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00723099
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT01251575
- Conditions
- Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
NCT01787409
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States